Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helio S Sader

Showing results (181-190 of 420) with videos related to

Pageof 42
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance ProgramHelio S Sader, Robert K Flamm, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE ProgramRobert K Flamm, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|October 30, 2012
Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistinHelio S Sader, Paul R Rhomberg, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2019
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centresHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
International Journal of Antimicrobial Agents|December 18, 2013
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011)Helio S Sader, Ronald N Jones, Matthew G Stilwell, et al.
Jac-Antimicrobial Resistance|September 8, 2022
Five-year analysis of the <i>in vitro</i> activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programmeCecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|June 9, 2005
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactamsSudha Pottumarthy, Yunson Yu, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|November 5, 2003
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002)Helio S Sader, Thomas R Fritsche, Alan H Mutnick, et al.
Diagnostic Microbiology and Infectious Disease|November 8, 2008
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agentHelio S Sader, Laura M Koeth, James A Poupard, et al.
Diagnostic Microbiology and Infectious Disease|November 15, 2011
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009)Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Pageof 42

Showing results (181-190 of 420) with videos related to

Sort By:
Pageof 42
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Activity analyses of staphylococcal isolates from pediatric, adult, and elderly patients: AWARE Ceftaroline Surveillance ProgramHelio S Sader, Robert K Flamm, David J Farrell, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 21, 2012
Ceftaroline potency among 9 US Census regions: report from the 2010 AWARE ProgramRobert K Flamm, Helio S Sader, David J Farrell, et al.
Diagnostic Microbiology and Infectious Disease|October 30, 2012
Use of a surfactant (polysorbate 80) to improve MIC susceptibility testing results for polymyxin B and colistinHelio S Sader, Paul R Rhomberg, Robert K Flamm, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2019
Antimicrobial activity of dalbavancin tested against Gram-positive organisms isolated from patients with infective endocarditis in US and European medical centresHelio S Sader, Rodrigo E Mendes, Michael A Pfaller, et al.
International Journal of Antimicrobial Agents|December 18, 2013
Ceftaroline activity tested against uncommonly isolated Gram-positive pathogens: report from the SENTRY Antimicrobial Surveillance Program (2008-2011)Helio S Sader, Ronald N Jones, Matthew G Stilwell, et al.
Jac-Antimicrobial Resistance|September 8, 2022
Five-year analysis of the <i>in vitro</i> activity of tedizolid against a worldwide collection of indicated species causing clinical infections: results from the Surveillance of Tedizolid Activity and Resistance (STAR) programmeCecilia G Carvalhaes, Helio S Sader, Jennifer M Streit, et al.
Diagnostic Microbiology and Infectious Disease|June 9, 2005
Susceptibility testing accuracy of a CTX-M-type extended-spectrum beta-lactamase organism-producing population of Enterobacteriaceae: intermethod analysis for 9 beta-lactamsSudha Pottumarthy, Yunson Yu, Helio S Sader, et al.
Diagnostic Microbiology and Infectious Disease|November 5, 2003
Contemporary evaluation of the in vitro activity and spectrum of cefdinir compared with other orally administered antimicrobials tested against common respiratory tract pathogens (2000-2002)Helio S Sader, Thomas R Fritsche, Alan H Mutnick, et al.
Diagnostic Microbiology and Infectious Disease|November 8, 2008
Interpretive categorical accuracy of fluoroquinolone reference broth microdilution MIC results when testing Streptococcus pneumoniae: selection of a surrogate testing agentHelio S Sader, Laura M Koeth, James A Poupard, et al.
Diagnostic Microbiology and Infectious Disease|November 15, 2011
Telavancin activity tested against a contemporary collection of Gram-positive pathogens from USA Hospitals (2007-2009)Rodrigo E Mendes, Helio S Sader, David J Farrell, et al.
Pageof 42